The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.
However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options.
myTomorrows Team
15 Apr 2025
4 mins read
myTomorrows Team
11 Apr 2025
14 mins read
myTomorrows Team
20 Mar 2025
10 mins read
myTomorrows Team
6 Mar 2025
11 mins read
myTomorrows Team
25 Feb 2025
10 mins read
myTomorrows Team
25 Feb 2025
5 mins read
myTomorrows Team
17 Feb 2025
5 mins read
myTomorrows Team
11 Feb 2025
11 mins read
Danny den Hamer
6 Feb 2025
6 mins read
Romina Dibra
14 Jan 2025
7 mins read